A detailed history of Simplify Asset Management Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Simplify Asset Management Inc. holds 47,252 shares of ABBV stock, worth $8.59 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
47,252
Previous 47,252 -0.0%
Holding current value
$8.59 Million
Previous $9.33 Million -0.0%
% of portfolio
0.5%
Previous 0.5%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$163.84 - $199.33 $7.74 Million - $9.42 Million
47,252 New
47,252 $9.33 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $1.62 Million - $1.85 Million
10,152 Added 114.16%
19,045 $3.47 Million
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $1.13 Million - $1.28 Million
-8,229 Reduced 48.06%
8,893 $1.38 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $575,505 - $666,232
4,308 Added 33.62%
17,122 $2.55 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $419,791 - $522,403
3,168 Added 32.84%
12,814 $1.73 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $562,966 - $648,340
3,893 Added 67.67%
9,646 $1.54 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $63,899 - $76,631
462 Added 8.73%
5,753 $930,000
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $221,446 - $253,984
1,650 Added 45.32%
5,291 $710,000
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $99,912 - $127,020
726 Added 24.91%
3,641 $558,000
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $384,721 - $477,331
2,915 New
2,915 $473,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $321B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Simplify Asset Management Inc. Portfolio

Follow Simplify Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Simplify Asset Management Inc. with notifications on news.